| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 640 |
| 1 | LEFLUNOMIDE | 620 |
| 2 | METHOTREXATE SODIUM | 617 |
| 3 | ADALIMUMAB | 615 |
| 4 | TOCILIZUMAB | 614 |
| 5 | DICLOFENAC SODIUM | 599 |
| 6 | DICLOFENAC | 592 |
| 7 | ETANERCEPT | 589 |
| 8 | METHOTREXATE | 587 |
| 9 | SECUKINUMAB | 582 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NEOMYCIN OINTMENT | 285 | 0.1199 |
| 1 | HYDROCORTISONE BUTYRATE | 168 | 0.0880 |
| 2 | DICLOFENAC POTASSIUM TABLETS | 474 | 0.0566 |
| 3 | TRIPROLIDINE HYDROCHLORIDE | 8 | 0.0442 |
| 4 | DICLOFENAC POTASSIUM | 474 | 0.0441 |
| 5 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 28 | 0.0437 |
| 6 | CAFFEINE CITRATE | 98 | 0.0434 |
| 7 | CORTISONE ACETATE | 464 | 0.0378 |
| 8 | PIROXICAM | 224 | 0.0353 |
| 9 | NAPROXEN SODIUM 220MG | 427 | 0.0317 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 703 |
| 1 | Corticosteroid [EPC] | 656 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 656 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 649 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 648 |
| 5 | Antirheumatic Agent [EPC] | 620 |
| 6 | Vitamin C [EPC] | 612 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 587 |
| 8 | Vitamin B12 [EPC] | 585 |
| 9 | Interleukin-17A Antagonist [EPC] | 582 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 86 | 0.0182 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 147 | 0.0075 |
| 2 | Tetracycline-class Drug [EPC] | 462 | 0.0067 |
| 3 | Antirheumatic Agent [EPC] | 620 | 0.0059 |
| 4 | Methylxanthine [EPC] | 295 | 0.0051 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 648 | 0.0048 |
| 6 | Interleukin-12 Antagonist [EPC] | 487 | 0.0048 |
| 7 | Histamine-1 Receptor Antagonist [EPC] | 383 | 0.0046 |
| 8 | Aminosalicylate [EPC] | 573 | 0.0043 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 516 | 0.0037 |